136 related articles for article (PubMed ID: 18302259)
1. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
Chang AR; Wu HG; Park CI; Jun YK; Kim CW
Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of EGF receptor expression in early glottic cancer.
Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
[TBL] [Abstract][Full Text] [Related]
3. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Eriksen JG; Steiniche T; Overgaard J;
Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
[TBL] [Abstract][Full Text] [Related]
4. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
5. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
[TBL] [Abstract][Full Text] [Related]
6. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
[TBL] [Abstract][Full Text] [Related]
7. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
8. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma.
Smith BD; Smith GL; Carter D; DiGiovanna MP; Kasowitz KM; Sasaki CT; Haffty BG
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):780-5. PubMed ID: 11448349
[TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
Psyrri A; Yu Z; Weinberger PM; Sasaki C; Haffty B; Camp R; Rimm D; Burtness BA
Clin Cancer Res; 2005 Aug; 11(16):5856-62. PubMed ID: 16115926
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
[TBL] [Abstract][Full Text] [Related]
11. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
13. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
14. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.
Yu Z; Weinberger PM; Haffty BG; Sasaki C; Zerillo C; Joe J; Kowalski D; Dziura J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Feb; 11(3):1160-6. PubMed ID: 15709184
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
[TBL] [Abstract][Full Text] [Related]
16. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
Cho EI; Kowalski DP; Sasaki CT; Haffty BG
Laryngoscope; 2004 Nov; 114(11):2001-8. PubMed ID: 15510031
[TBL] [Abstract][Full Text] [Related]
17. Early glottic carcinoma: patterns and predictors of relapse after definitive radiotherapy.
Kersh CR; Kelly MD; Hahn SS; Spaulding CA; Cantrell RW; Constable WC
South Med J; 1990 Apr; 83(4):374-8. PubMed ID: 2321065
[TBL] [Abstract][Full Text] [Related]
18. Late local recurrence after radiotherapy for tongue and early glottic carcinoma.
Inoue T; Inoue T; Teshima T; Murayama S; Nose T; Tanaka E; Yamazaki H; Koizumi M; Kagawa K; Ozeki S; Ikeda H
Strahlenther Onkol; 1996 Jun; 172(6):301-5. PubMed ID: 8677501
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of cyclin D1 in breast cancer.
Bilalović N; Vranić S; Basić H; Tatarević A; Selak I
Croat Med J; 2005 Jun; 46(3):382-8. PubMed ID: 15861516
[TBL] [Abstract][Full Text] [Related]
20. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]